Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Neuvivo Seeks FDA Approval for Its Breakthrough ALS Treatment NP001
Details : NP001 is an investigational product (sodium chlorite), which is being investigated in the late-stage clinical trial for the treatment of amyotrophic lateral sclerosis.
Brand Name : NP001
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 07, 2024
LOOKING FOR A SUPPLIER?